Observation of clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia
Abstract
Objective:To observe the clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia.Methods:66 patients were randomly divided into 2 groups,33 patients were treated with Moxifloxacin(treatment group) and 33 patients were treated with Levofloxacin(control group).Results:The effective rate,bacterial clearing rate and occurrence of the adverse reaction for treatment group were 90.91%,93.94%,9.09% respectively and for control group were 78.79%,81.82%,12.12% respectively,the effective rate,bacterial clearing rate of two groups were compared,the differences were statistically significant(P0.05),while the adverse reaction of two groups were compared,the difference was not significant(P0.05).Conclusion:Moxifloxacin is a safe and effective medicine for treating elderly patients with acute pneumonia.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.